Anti-apoptotic effect of interleukin-22 on fibroblast-like synoviocytes in patients with rheumatoid arthritis is mediated via the signal transducer and activator of transcription 3 signaling pathway

International Journal of Rheumatic Diseases

Volumn 20, Issue 2, 2017, Pages 214-224

  Zhao, Min ^a,b   Li, Yishuo ^a   Xiao, Weiguo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; IL 22; RA FLS; STAT3

Indexed keywords

INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR 1; INTERLEUKIN RECEPTOR; NITROPRUSSIDE SODIUM; PROTEIN BCL 2; PROTEIN BCL XL; STAT3 PROTEIN; UNCLASSIFIED DRUG; BCL2 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; STAT3 PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CASE REPORT; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; DRUG EFFECTS; HEP-G2 CELL LINE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TIME FACTOR;

AGED; APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL SURVIVAL; CYTOPROTECTION; HEP G2 CELLS; HUMANS; INTERLEUKINS; MIDDLE AGED; NITROPRUSSIDE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SYNOVIOCYTES; TIME FACTORS;

EID: 84982903054     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12939     Document Type: Article

References (47)

1. Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373, 659–72.
2. Kvien TK (2004) Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22, 1–12.
3. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356–61.
4. Lefevre S, Meier FM, Neumann E et al. (2015) Role of synovial fibroblasts in rheumatoid arthritis. Curr Pharm Des 21, 130–41.
5. McInnes IB, Leung BP, Field M et al. (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184, 1519–24.
6. Borderie D, Hilliquin P, Hernvann A et al. (1999) Apoptosis induced by nitric oxide is associated with nuclear p53protein expression in cultured osteoarthritic synoviocytes. Osteoarthritis Cartilage 7, 203–13.
7. Lee S-Y, Kwok S-K, Son H-J et al. (2013) IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation. Arthritis Res Ther 15, R31.
8. Liu Y, Mei C, Du R, Shen L (2013) Protective effect of allograft inflammatory factor-1 on the apoptosis of fibroblast-like synoviocytes in patients with rheumatic arthritis induced by nitro oxide donor sodium nitroprusside. Scand J Rheumatol 42, 349–55.
9. Li H, Wan A (2013) Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the Thioredoxin 1[J]. Mediators Inflamm 2013, 189–214.
10. Firestein GS (2009) Kelly's Textbook of Rheumatology, 8th edn. pp. 1035–86. Saunders Elsevier, Philadelphia, PA.
11. Pap T, Gay S (2009) Kelly's Textbook of Rheumatology, 8th edn. pp. 201–14. Saunders Elsevier, Philadelphia, PA.
12. Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233, 233–55.
13. Dumoutier LJ, Enauld JC (2000) Cloning and Characterization of IL-10-related T cell-derived factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164, 1814–9.
14. Dumoutier L, Van Roost E, Colau D et al. (2000) Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 97, 10144–9.
15. Lim C, Savan R (2014) The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev 25, 257–71.
16. Qiang X, Cheng H, Jun L (2015) Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy. [J]. Autoimmunity 48, 1–4.
17. Lerman G, Sharon M, Leibowitz-Amit R et al. (2014) The crosstalk between IL-22 signaling and miR-197 in human keratinocytes. PLoS One 9, e107467.
18. Works MG, Yin F, Yin CC et al. (2014) Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis. J Immunol 193, 3278–87.
19. Ciccia F, Guggino G, Giardina A et al. (2014) The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome. Expert Rev Clin Immunol 10, 533–41.
20. Zhao L, Jiang Z, Jiang Y et al. (2013) IL-22 + CD4 + T-cells in patients with active systemic lupus erythematosus. Exp Biol Med (Maywood) 238, 193–9.
21. Zhao L, Ma H, Jiang Z et al. (2014) Immunoregulation therapy changes the frequency of interleukin (IL)-22 + CD4 + T cells in systemic lupus erythematosus patients. Clin Exp Immunol 177, 212–8.
22. Lin J, Yue LH, Chen WQ (2014) Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus. Scand J Immunol 79, 131–6.
23. Ikeuchi H, Kuroiwa T, Hiramatsu N et al. (2005) Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 52, 1037–46.
24. Zhu J, Jia E, Zhou Y et al. (2015) Interleukin-22 Secreted by NKp44 + Natural Killer Cells Promotes Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis. [J]. Medicine (Baltimore) 94, e2137.
25. Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315–24.
26. Zhu X, Xiao L, Huo R et al. (2013) Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 15 (6), R187.
27. Dumoutier L, van Roost E, Colau D et al. (2000) Human cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 97, 10144–9.
28. Bournazoua E, Brombergab J (2013) Targeting the tumor microenvironment: JAK-STAT3 signaling. JAKSTAT 2, e23828.
29. Da Rocha LF Jr, Duarte ÂL, Dantas AT et al. (2012) Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J Rheumatol 39, 1320–5.
30. Zhao L, Jiang Z, Jiang Y et al. (2013) IL-22 + CD4 + T cells in patients with rheumatoid arthritis. Int J Rheum Dis 16, 518–26.
31. Justa S, Zhou X, Sarkar S (2014) Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses. PLoS One 27, e93279.
32. Ren J, Zhou Y, Wu H et al. (2014) Role and mechanism of NKp44 + NK cells in the proliferation and inflammation of synovium of rheumatoid arthritis patients. Zhonghua Yi Xue Za Zhi 94, 201–3.
33. Geboes L, Dumoutier L, Kelchtermans H et al. (2009) Proinflammtatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 60, 390–5.
34. Kim KW, Kim HR, Kim BM et al. (2015) Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Am J Pathol 185, 3011–24.
35. Decker T, Kovarik P (2000) Serine phosphorylation of STATs. Oncogene 19, 2628–37.
36. Yu H, Jove R (2004) The STATs of cancer–new molecular targets come of age. Nat Rev Cancer 4, 97–105.
37. Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9, 798–809.
38. Jiang R, Tan Z, Deng L et al. (2011) Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 54, 900–9.
39. Curd LM, Favors SE, Gregg RK (2012) Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells. Clin Exp Immunol 168, 192–9.
40. Zhang W, Chen Y, Wei H et al. (2008) Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res 14, 6432–9.
41. Carrión M, Juarranz Y, Martínez C et al. (2013) IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. Rheumatology 52, 2177–86.
42. Krause A, Scaletta N, Ji JD et al. (2002) Rheumatoid arthritis synoviocyte survival is dependent on STAT3. J Immunol 169, 6610–6.
43. Song H, Wang R, Wang S et al. (2005) A low-molecular-weight compound discovered through virtual database screening inhibits STAT3 function in breast cancer cells. Proc Natl Acad Sci USA 102, 4700–5.
44. Rath KS, Shan K, Lata P et al. (2014) HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer. Cancer Res 74, 2316–27.
45. Tierney BJ, McCann GA, Cohn DE et al. (2012) HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells. Cancer Biol Ther 9, 766–75.
46. Tierney BJ, Karuppaiyah Selvendiran GA, Tong L et al. (2010) Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts. Mol Cancer Ther 9, 1169–79.
47. Selvendiran K, Ahmed S, Dayton A et al. (2010) Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluoro diarylidenylpiperidones: differential cytotoxicity in healthy and cancer cells. Free Radic Biol Med 48, 1228–35.